| Authors: |
Chadban S; Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Esposito C; ICS Maugeri, Pavia, Italy.; Department of Internal Medicine and Therapy, University of Pavia, Pavia, Italy., Correa-Rotter R; Department of Nephrology and Mineral Metabolism, National Medical Science and Nutrition Institute Salvador Zubirán, Mexico City, Mexico., Wu MS; College of Medicine, Taipei Medical University, Taipei, Taiwan., Reichel H; Nephrological Center, Villingen-Schwenningen, Germany., Elsayed HM; Department of Internal Medicine and Nephrology, Faculty of Ain Shams University, Cairo, Egypt., Garcia Sanchez JJ; Global Market Access & Pricing, AstraZeneca, Cambridge, UK. juanjose.garciasanchez@astrazeneca.com., Pentakota S; Global Medical Affairs, Biopharmaceuticals Medical, AstraZeneca, Cambridge, UK., Kularatne T; CaPPRe: Community and Patient Preference Research, Sydney, NSW, Australia., Fifer S; CaPPRe: Community and Patient Preference Research, Sydney, NSW, Australia., Hull R; Renal and Transplantation Unit, St George's University Hospital NHS Foundation Trust, London, UK. |
